Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
OOP Costs for Buprenorphine Down, But Could Still Present a Barrier for Some
03/06/2023
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket...
03/06/2023
First Report Managed Care
News
IV Bags Recalled Over Sterility Concerns
03/02/2023
B. Braun Medical Inc is recalling more than 1 million bags of sodium chloride solution because of leaks.
B. Braun Medical Inc is recalling more than 1 million bags of sodium chloride solution because of leaks.
B. Braun Medical Inc is...
03/02/2023
Pharmacy Learning Network
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network

Advertisement

News
Blood Thinner Recalled
03/02/2023
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
News
Anesthetic Products Recalled
02/23/2023
Two types of anesthetics are under a Class II recall due to discolored epinephrine.
Two types of anesthetics are under a Class II recall due to discolored epinephrine.
Two types of anesthetics are...
02/23/2023
Pharmacy Learning Network
News
Beta-Blocker Recalled
02/23/2023
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for...
02/23/2023
Pharmacy Learning Network

Advertisement

News
Surgical Scrub Recalled
02/23/2023
A Class II recall has been issued for multiple lots of surgical antiseptic.
A Class II recall has been issued for multiple lots of surgical antiseptic.
A Class II recall has been...
02/23/2023
Pharmacy Learning Network
News
Screening for Social Needs Outside the Comfort Zone of Community Pharmacists
02/16/2023
Data demonstrates that when social needs are addressed, medication adherence rates are improved; however, many pharmacists expressed they lack confidence and comfort screening patients in a recent survey.
Data demonstrates that when social needs are addressed, medication adherence rates are improved; however, many pharmacists expressed they lack confidence and comfort screening patients in a recent survey.
Data demonstrates that when...
02/16/2023
Pharmacy Learning Network
News
Antifungal Tablets Recalled
02/16/2023
Multiple lots of delayed-release antifungal tablets are under a Class II recall due to out-of-specification degradation results during routine testing.
Multiple lots of delayed-release antifungal tablets are under a Class II recall due to out-of-specification degradation results during routine testing.
Multiple lots of delayed-release...
02/16/2023
Pharmacy Learning Network

Advertisement

News
Pharmacist-Led Antibiotic Intervention Decreases Hospital Readmissions
02/16/2023
“Pharmacist expertise on patient habits, compliance, and self-treatment autonomy is of key importance in the choice of antibiotic therapy,” researchers advised.
“Pharmacist expertise on patient habits, compliance, and self-treatment autonomy is of key importance in the choice of antibiotic therapy,” researchers advised.
“Pharmacist expertise on patient...
02/16/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use